EZPW vs. GMED
EZPW (EZCORP, Inc.) and GMED (Globus Medical, Inc.) are both stocks. EZPW operates in Credit Services (Financial Services), while GMED operates in Medical Devices (Healthcare). Over the past 10 years, EZPW returned 13.43%/yr vs 12.07%/yr for GMED. At a 0.20 correlation, their price movements are largely independent.
Performance
EZPW vs. GMED - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EZPW achieves a 75.44% return, which is significantly higher than GMED's -10.54% return. Over the past 10 years, EZPW has outperformed GMED with an annualized return of 13.43%, while GMED has yielded a comparatively lower 12.07% annualized return.
EZPW
- 1D
- 0.00%
- 1M
- 10.80%
- 6M
- 59.43%
- YTD
- 75.44%
- 1Y
- 140.10%
- 3Y*
- 58.17%
- 5Y*
- 41.25%
- 10Y*
- 13.43%
GMED
- 1D
- 1.92%
- 1M
- -2.99%
- 6M
- -17.32%
- YTD
- -10.54%
- 1Y
- 36.75%
- 3Y*
- 8.91%
- 5Y*
- -0.63%
- 10Y*
- 12.07%
EZPW vs. GMED - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EZPW EZCORP, Inc. | 75.44% | 58.92% | 39.82% | 7.24% | 10.58% | 53.86% | -29.77% | -11.77% | -36.64% | 14.55% |
GMED Globus Medical, Inc. | -10.54% | 5.56% | 55.21% | -28.25% | 2.87% | 10.70% | 10.77% | 36.04% | 5.30% | 65.66% |
Correlation
The correlation between EZPW and GMED is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Aug 3, 2012 | 0.20 |
Fundamentals
EZPW:
$2.00B
GMED:
$10.53B
EZPW:
$1.76
GMED:
$4.28
EZPW:
19.36
GMED:
18.23
EZPW:
0.13
GMED:
0.19
EZPW:
1.92
GMED:
3.45
EZPW:
2.54
GMED:
2.28
EZPW:
$1.48B
GMED:
$3.10B
EZPW:
$865.21M
GMED:
$1.58B
EZPW:
$256.16M
GMED:
$803.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EZPW vs. GMED — Risk / Return Rank
EZPW
GMED
EZPW vs. GMED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for EZCORP, Inc. (EZPW) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EZPW | GMED | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.22 | ||
| Sortino ratioReturn per unit of downside risk | +2.42 | ||
| Omega ratioGain probability vs. loss probability | 1.58 | 1.21 | +0.37 |
| Calmar ratioReturn relative to maximum drawdown | 9.11 | 1.60 | +7.51 |
| Martin ratioReturn relative to average drawdown | 32.14 | 3.87 | +28.27 |
Loading charts...
Drawdowns
EZPW vs. GMED - Drawdown Comparison
The maximum EZPW drawdown since its inception was -97.28%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for EZPW and GMED.
Loading charts...
Drawdown Indicators
| EZPW | GMED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.28% | -47.91% | -49.37% |
Max Drawdown (1Y)Largest decline over 1 year | -16.19% | -22.10% | +5.91% |
Max Drawdown (3Y)Largest decline over 3 years | -20.51% | -44.40% | +23.89% |
Max Drawdown (5Y)Largest decline over 5 years | -35.94% | -47.91% | +11.97% |
Max Drawdown (10Y)Largest decline over 10 years | -76.59% | -47.91% | -28.68% |
Current DrawdownCurrent decline from peak | -10.51% | -19.32% | +8.81% |
Average DrawdownAverage peak-to-trough decline | -59.00% | -15.33% | -43.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.58% | 9.13% | -4.55% |
Volatility
EZPW vs. GMED - Volatility Comparison
EZCORP, Inc. (EZPW) has a higher volatility of 19.30% compared to Globus Medical, Inc. (GMED) at 13.69%. This indicates that EZPW's price experiences larger fluctuations and is considered to be riskier than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EZPW | GMED | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.30% | 13.69% | +5.61% |
Volatility (6M)Calculated over the trailing 6-month period | 29.72% | 25.33% | +4.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.56% | 49.46% | -11.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.42% | 38.27% | -3.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.98% | 35.68% | +3.30% |
Dividends
EZPW vs. GMED - Dividend Comparison
Neither EZPW nor GMED has paid dividends to shareholders.
Financials
EZPW vs. GMED - Financials Comparison
This section allows you to compare key financial metrics between EZCORP, Inc. and Globus Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EZPW vs. GMED - Profitability Comparison
EZPW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, EZCORP, Inc. reported a gross profit of 260.04M and revenue of 446.88M. Therefore, the gross margin over that period was 58.2%.
GMED - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.
EZPW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, EZCORP, Inc. reported an operating income of 67.84M and revenue of 446.88M, resulting in an operating margin of 15.2%.
GMED - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.
EZPW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, EZCORP, Inc. reported a net income of 49.10M and revenue of 446.88M, resulting in a net margin of 11.0%.
GMED - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.
Frequently Asked Questions
EZPW and GMED have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EZPW has higher volatility (19.30%) compared to GMED (13.69%). In terms of maximum drawdown, EZPW dropped -97.28% vs GMED's -47.91%.
EZPW currently has the higher Sharpe Ratio (3.94 vs 0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EZPW and GMED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer